IL1/IL1 Ra, CTLA-4 and Apo1/Fas genes polymorphisms and susceptibility to IgA nephropathy in Tunisian patients.

##plugins.themes.academic_pro.article.sidebar##

Published Oct 27, 2010
Download
pdf
Vol. 88 No. 11 (2010): Issue Nov 2010

##plugins.themes.academic_pro.article.main##

Yosr Gorgi
Imene Sfar
Rym Goucha
Houda Aouadi
Mohamed Amri
Mouna Makhlouf
Thouraya Ben Romdhane
Mejda Cherif
Salwa Jendoubi-Ayed
Taeib Ben Abdallah
Khaled Ayed

Abstract

Background: The IgA nephropathy (IgA-N) is considered the most common form of primary glomerulonephritis and its pathogenic mechanisms are very complex. The study of several genes which encode for immunoregulator molecules in inflammatory and immunological responses during the disease, allowed to describe some number of polymorphisms would be involved in the molecular expression, the road marking, the synthesis and\or the binding to the receptors. So an abnormality of the molecular function associated with its polymorphism would be suggested in the genetic predisposition to the disease.
Aim: To determine interleukin 1 (IL1), interleukin1 receptor antagonist (IL1 Ra), CTLA-4 and Apo1/Fas genes polymorphisms frequencies in IgA-N in order to estimate the impact of these polymorphisms in the disease susceptibility.
Methods: The polymorphism of a single nucleotide (SNP) at (-889) IL1 a of 21 IgA-N patients and 100 healthy blood donors, as controls, was studied by PCRSSP. The SNPs of the IL1 ß (+3954), CTLA-4 (+49) and l'Apo1/Fas were analyzed by PCR RFLP and finally the polymorphism of the IL1 Ra gene was determined by a PCR VNTR (variable number tandem repeat).
Results: Investigation of IL1a/ß and Apo1/Fas polymorphisms showed no differences in genotypes and alleles frequencies between IgA-N patients and controls. However, genotype AA of CTLA-4 exon1 (+49) was significantly higher in patients (47,62%) than in controls (9,1%) p<0,001. Nevertheless, the clinical, histological and biological characteristics of IgA-N were similar in AA CTLA-4 genotype patients compared to AG or GG genotype patients. We fund also, a significant increased frequency of 1/1 IL1 Ra genotype in IgA-N patients (95,24%) compared to controls (54%) (p<0,001) (p < 0,001).
Conclusion: We conclude that the susceptibility to IgA-N seems to be associated with the presence of CTLA-4 AA and IL1 Ra 1/1 genotypes in Tunisian population. However, the lack of association between IL1 a/ß and Apo1/fas genes polymorphisms should be further investigated by large population based studies.

Keywords:

IgA-nephropathy, gene, polymorphism, IL1, CTLA-4, Apo/Fas

##plugins.themes.academic_pro.article.details##

References

  1. Monteiro RC, Leroy V, Launay P, Moura IC. Pathogenesis of Berger's disease: recent advances on the involvement of immunoglobulin A and their receptors. Med Sci 2003; 19: 1233-41.
  2. Chen A, Chen WP, Sheu LF, Lin CY. Patogenesis of IgA nephropathy: in vitro activation of human mesangial cells by IgA immune complex leads to cytokine secretion. J Pathol 1994; 173: 119-26.
  3. Kashem A, Endoh M, Yano N, Yamauchi F, Nomoto Y, Sakai H, Kurokawa K. Glomerular Fc alphaR expression and disease activity in IgA nephropathy. Am J Kidney Dis 1997; 30: 389-96.
  4. Lim CS, Yoon HJ, Kim YS, Ahn C, Han JS. Clinicopathological correlation of intrarenal cytokines and chemokines in IgA nephropathy. Nephrology (Carlton) 2003; 8: 21-7.
  5. Haas M. Histology and immunohistology of IgA nephropathy. J Nephrol 2005; 18: 676-80.
  6. Zwirner J, Burg M, Schulze M, et al. Activated complement C3: A potentially novel predictor of progressive IgA nephropathy. Kidney Int 1997; 51: 1257-64.
  7. Chun Soo Lim, Shouhuan Zheng, Yon Su Kim, et al. Thi/Th2 predominance and proinflammatory cytokines determine the clinicopathological severity of IgA nephropathy. Nephrology Dialysis Transplantation 2001; 16: 269-75.
  8. Chin HJ, Na KY, Kim SJ, et al.. Interleukin-10 promoter polymorphism is associated with the predisposition to the development of IgA nephropathy and focal segmental glomerulosclerosis in Korea. J Korean Med Sci 2005; 20: 989-93.
  9. Schena FP, Cerullo G, Torres DD, et al. Role of interferon-gamma gene polymorphisms in susceptibility to IgA nephropathy: a family-based association study. Eur J Hum Genet 2006; 14: 488- 96.
  10. Taniguchi Y, Yorioka N, Oda H, Yamakido M. Platelet-derived growth factor, interleukin (IL)-1 beta, IL-6R and tumor necrosis factor-alpha in IgA nephropathy. An immunohistochemical study. Nephron 1996; 74: 652-60.
  11. Liu ZH, Cheng ZH, Yu YS, Tang Z, Li LS. Interleukin-1 receptor antagonist allele: is it a genetic link between Henoch-Schonlein nephritis and IgA nephropathy? Kidney Int 1997; 51: 1938-42.
  12. Shu KH, Lee SH, Cheng CH, Wu MJ, Lian JD. Impact of interleukin-1 receptor antagonist and tumor necrosis factor-alpha gene polymorphism on IgA nephropathy. Kidney Int 2000; 58: 783-9.
  13. Watanabe M, Iwano M, Akai Y, et al. Association of interleukin- 1 receptor antagonist gene polymorphism with IgA nephropathy. Nephron 2002; 91: 744-6.
  14. Kodama S, Suzuki M, Arita M, Mogi G. Increase in tonsillar germinal centre B-1 cell numbers in IgA nephropathy (IgAN) patients and reduced susceptibility to Fas-mediated apoptosis. Clin Exp Immunol 2001; 123: 301-8.